Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
APPROVALS
Page 5
APPROVALS
APPROVALS
Xenpozyme (olipudase alfa) approved in Japan as first and only approved therapy indicated to treat acid sphingomyelinase deficiency
Tess Egginton
-
31st March 2022
0
APPROVALS
Beckman Coulter achieves CE Mark for its MDW-SARS CoV-2 application as an aid in identifying patients with risk of COVID-19 in A&E
Tess Egginton
-
23rd March 2022
0
APPROVALS
NHS fast tracks new “gamechanging” drug for lung cancer
Tess Egginton
-
22nd March 2022
0
APPROVALS
MHRA approves AstraZeneca’s Evusheld for COVID-19 prevention
Tess Egginton
-
21st March 2022
0
APPROVALS
FDA approves first generic of Symbicort to treat asthma and COPD
Tess Egginton
-
16th March 2022
0
APPROVALS
BeiGene receives Health Canada approval for BRUKINSA® in relapsed or refractory marginal zone lymphoma
Tess Egginton
-
8th March 2022
0
APPROVALS
NICE draft guidance recommends tucatinib for advanced breast cancer
Tess Egginton
-
2nd March 2022
0
APPROVALS
FDA approves treatment for wider range of patients with heart failure
Tess Egginton
-
25th February 2022
0
APPROVALS
Saphnelo becomes first new medicine for systemic lupus erythematosus to gain approval in Europe in over a decade
Tess Egginton
-
17th February 2022
0
APPROVALS
Lilly’s bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19
Tess Egginton
-
15th February 2022
0
1
...
4
5
6
...
11
Page 5 of 11
